Swiss National Bank Reduces Holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Swiss National Bank lessened its holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 1.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 63,500 shares of the semiconductor company’s stock after selling 700 shares during the period. Swiss National Bank owned 0.19% of Axcelis Technologies worth $6,658,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of ACLS. CWM LLC lifted its stake in Axcelis Technologies by 4.8% in the 2nd quarter. CWM LLC now owns 1,506 shares of the semiconductor company’s stock valued at $214,000 after buying an additional 69 shares in the last quarter. Xponance Inc. boosted its stake in shares of Axcelis Technologies by 4.7% during the second quarter. Xponance Inc. now owns 2,061 shares of the semiconductor company’s stock valued at $293,000 after acquiring an additional 92 shares during the last quarter. Andina Capital Management LLC boosted its stake in shares of Axcelis Technologies by 3.7% during the second quarter. Andina Capital Management LLC now owns 2,791 shares of the semiconductor company’s stock valued at $397,000 after acquiring an additional 99 shares during the last quarter. Advisors Asset Management Inc. increased its position in Axcelis Technologies by 17.5% during the 1st quarter. Advisors Asset Management Inc. now owns 670 shares of the semiconductor company’s stock worth $75,000 after purchasing an additional 100 shares in the last quarter. Finally, Evergreen Capital Management LLC raised its stake in Axcelis Technologies by 6.1% in the 2nd quarter. Evergreen Capital Management LLC now owns 1,984 shares of the semiconductor company’s stock valued at $282,000 after purchasing an additional 114 shares during the last quarter. 89.98% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ACLS has been the subject of a number of recent research reports. Benchmark downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a research note on Friday, November 8th. Finally, B. Riley reduced their price target on Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $167.33.

Axcelis Technologies Stock Down 3.9 %

Shares of NASDAQ ACLS opened at $74.45 on Wednesday. The stock has a market capitalization of $2.42 billion, a PE ratio of 11.01, a P/E/G ratio of 2.34 and a beta of 1.60. The company has a quick ratio of 3.29, a current ratio of 4.45 and a debt-to-equity ratio of 0.04. The firm has a fifty day moving average of $91.06 and a 200-day moving average of $110.67. Axcelis Technologies, Inc. has a 52-week low of $69.35 and a 52-week high of $158.61.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.